Improving Pharmaceuticals for Children Act of 2007

H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. S 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; S 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; HR 4083 / S 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of mongraphs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; S 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.

Client expense: $1,700,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act; S 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; S 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; HR 4083 / S 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of mongraphs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; S 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.

Client expense: $1,440,000 · Firm income: Not reported

H.R. 2723, S. 1226, "Children's Health Care Quality Act," all provisions. H.R. 1308, S. 764, "Legal Immigrant Children's Health Improvement Act," all provisions. S. 1156, "Best Pharamaceuticals For Children Amendments of 2007," all provisions. H.R. 2589, "Imporving Pharamecuticals for Children Act of 2007," all provisions. S. 993, "Pediatric Research Improvement Act," all provisions. H.R. 1494, S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," all provisions. S. 1082, "Food and Drug Administration Revitalization Act," provisions relating to pharmaceutical and medical device testing for children. H.R. 2900, "Food and Drug Administration Amendments Act of 2007," provisions relating to pharmaceutical and medical device testing for children S. 1970, Addressing the Disaster Needs of Children Act, all provisions. S. 911/H.R. 1553, Conquer Childhood Cancer Act, all provisions. H.R. 4450, Pediatric, Adolescent, and Young Adult Cancer Survivorship Research and Quality of Life Act, all provisions.

Client expense: $834,165 · Firm income: Not reported

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

Client expense: $3,000,000 · Firm income: Not reported

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

HR 2589, Improving Pharmaceuticals for Children Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act;

Client expense: $3,880,000 · Firm income: Not reported

S 242, “Pharmaceutical Market Access and Drug Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, “Pharmaceutical Market Access Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs. HR 2589, “Improving Pharmaceuticals for Children Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act; S 1156, “Best Pharmaceuticals for Children Amendments of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program;

Client expense: $3,820,000 · Firm income: Not reported

S. 1156, “Best Pharmaceuticals For Children Amendments of 2007,” all provisions. H.R. 2589, “Improving Pharmaceuticals for Children Act of 2007,” all provisions. S. 993, “Pediatric Research Improvement Act,” all provisions. H.R. 1494, S. 830, “Pediatric Medical Device Safety and Improvement Act of 2007,” all provisions. S. 1082, “Food and Drug Administration Revitalization Act,” provisions relating to pharmaceutical and medical device testing for children. H.R. 2900, “Food and Drug Administration Amendments Act of 2007,” provisions relating to pharmaceutical and medical device testing for children. H.R. 2723, S. 1226, “Children’s Health Care Quality Act,” all provisions. H.R. 1308, S. 764, “Legal Immigrant Children’s Health Improvement Act,” all provisions.

Client expense: $1,234,877 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's access to health insurance Immunizations WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Medikids Health Insurance Act of 2007 Ephedrine Alkaloid Consumer Protection Act Immunization Coding Issues Paul Wellstone Mental Health and Addiction Equity Act (HR 1424) Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Health Information Technology/Electronic Health Records Emergency Medical Services for Children Act Reauthorization Injury Prevention Best Pharmaceuticals for Children Act (HR 2589) Pediatric Research Equity Act (S.993) Children and Families HIV/AIDS Care and Research Act Pediatric Medical Device Safety and Improvement Act of 2007 (HR 1494/S. 830) Ryan White CARE Act Child Health Care Crisis Relief Act Enhancing Drug Safety and Innovation Act Mental Health Parity Lower PRICED Drugs Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Reauthorization of SCHIP S. 588 Resident Physician Shortage Reduction Act HR 3/S. 5 Stem Cell Research Enhancement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Heed Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act HR 1153 Parental Right to Decide Protection Act Access to Life-Saving Medicine Act Biologics Price Competition and Innovation Act of 2007 Food and Drug Administration Revitalization Act S. 1082 Food and Drug Administration Amendments Act of 2007 HR 2900 Improving Pharmaceuticals for Children Act of 2007 HR 2589 Best Pharmaceuticals for Children Amendments of 2007 S. 1156 Pediatric Research Improvement Act S. 993 School-Based Health Clinics Establishment Act Early Hearing and Detection and Intervention Family Smoking Prevention and Tobacco Control Act Prescription Drug User Fee Act FACT Act State Children's Health Insurance Program (SCHIP) Managed Care Reform

Stem Cell Research Enhancement Act of 2005 HR 3/S.5 Clinical Trials Registry National Children's Study Preservation of Antibiotics of Medical Treatment Act Pediatric Medical Device Study and Improvement Act of 2007 HR 1424/S. 830 Ryan White CARE Act Patient Safety and Quality Improvement Act Best Pharmaceuticals for Children Act Preemie Act HR 2184 Enhanced Health Care Value For All Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act Pediatric Research Equity Act Access to Life-Saving Medicine Act Biologics Price Competition and Innovation Act of 2007 Food and Drug Administration Revitalization Act S. 1082 Food and Drug Administration Amendments Act of 2007 HR 2900 Improving Pharmaceuticals for Children Act of 2007 HR 2589 Best Pharmaceuticals for Children Amendments of 2007 S. 1156 Pediatric Research Improvement Act S. 993 School-Based Health Clinics Establishment Act Early Hearing and Detection and Intervention Family Smoking Prevention and Tobacco Control Act Prescription Drug User Fee Act FACT Act

Client expense: $160,000 · Firm income: Not reported